DB16920ExperimentalProtein Based Therapies
Priliximab: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on T-cell surface glycoprotein CD4
- Also known as
- CEN 000029 · Chimeric M-T412 (human-murine) IgG monoclonal anti-CD4 · cMT 412 · MT 412
Resolves to
Compound
Targets
What you can answer from here — as of June 15, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with Priliximab, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account